Skip to main content

Cesarean Section Complications

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Raydiant Oximetry
Raydiant OximetryCA - San Ramon
1 program
DAISY Uterine DrainN/A1 trial
Active Trials
NCT06219538Completed10Est. Apr 2025
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Empowered ReliefN/A2 trials
Active Trials
NCT07799883Not Yet Recruiting30Est. Mar 2027
NCT07192718Enrolling By Invitation60Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
Human BioSciencesEmpowered Relief
Human BioSciencesEmpowered Relief
Raydiant OximetryDAISY Uterine Drain

Clinical Trials (3)

Total enrollment: 100 patients across 3 trials

Reducing Chronic Pain Following Cesarean Delivery

Start: Oct 2026Est. completion: Mar 202730 patients
N/ANot Yet Recruiting

Using Empowered Relief and Education To Help Postpartum Women Recover After Cesarean Delivery

Start: Dec 2025Est. completion: Dec 202660 patients
N/AEnrolling By Invitation
NCT06219538Raydiant OximetryDAISY Uterine Drain

DAISY Uterine Drain Device Evaluation

Start: May 2024Est. completion: Apr 202510 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.